Abacus Medicine, a Danish-based pharmaceutical provider, that last week published its intention to go public has postponed the IPO due to unfavourable market conditions. The same happened in fall 2018 where Abacus also postponed its IPO.
ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library
. If you would like more insights on this deal or industry then send us an email at firstname.lastname@example.org